Unverified50% confidenceSolutionExact time
The study treats cancer types as latent subject entities (corresponding to drug resistance ability parameters), treats drugs as items (corresponding to escape difficulty parameters), and maps them onto the same latent scale to achieve comparable ranking.
1
Sources
50%
Confidence
Long-term
Relevance
10/4/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedWhen evaluating carcinogenicity information, one should focus on absolute risk rather than relative risk, distinguish between strength of evidence and magnitude of risk, and be wary of conclusions drawn from single studies.72% similarUnverifiedThrough bootstrap confidence interval analysis, 19 out of 28 cancer types had stable drug-resistant/sensitive classification results.70% similarUnverifiedThe authors position the contribution of this study as methodological robustness under fragmented assessment, rather than providing a clinical drug resistance ranking.68% similarUnverifiedThe carcinogen classifications of the IARC (International Agency for Research on Cancer) measure the strength of evidence, not the magnitude of risk.67% similarUnverifiedA large amount of carcinogenicity research is based on epidemiological observational data, making it difficult to rule out confounding factors.65% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/971746API
curl https://kongchang.com/api/v1/knowledge/claims/971746MCP
get_claim(id=971746)